Bausch Health Companies Inc. (BHC)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Salix Revenue	2.68B	2.58B	2.33B
Salix Revenue Growth	3.76%	10.50%	3.69%
International Rx Revenue	1.16B	1.13B	1.11B
International Rx Revenue Growth	2.03%	1.89%	3.74%
Solta Medical Revenue	576.00M	518.00M	440.00M
Solta Medical Revenue Growth	11.20%	17.73%	26.80%
Diversified Products Revenue	917.00M	937.00M	950.00M
Diversified Products Revenue Growth	-2.13%	-1.37%	0.74%
Bausch + Lomb Revenue	5.21B	5.10B	4.79B
Bausch + Lomb Revenue Growth	2.10%	6.47%	15.56%
Revenue (Other)	1.35B	-	-
Revenue (Total)	11.88B	10.27B	9.63B
Revenue (Total) Growth	15.73%	6.66%	9.91%

EBIT

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Salix Segment Profit	2.02B	1.93B	1.60B
Salix Segment Profit Growth	5.04%	20.16%	3.49%
International Rx Segment Profit	337.00M	334.00M	376.00M
International Rx Segment Profit Growth	0.90%	-11.17%	12.24%
Solta Medical Segment Profit	254.00M	232.00M	213.00M
Solta Medical Segment Profit Growth	9.48%	8.92%	32.30%
Diversified Products Segment Profit	612.00M	627.00M	626.00M
Diversified Products Segment Profit Growth	-2.39%	0.16%	6.83%
Bausch + Lomb Segment Profit	1.22B	1.13B	1.11B
Bausch + Lomb Segment Profit Growth	8.62%	1.53%	13.06%
Operating Income (Total)	789.92M	1.81B	1.55B
Operating Income (Total) Growth	-56.43%	17.27%	60.54%

Updated Apr 29, 2026. Data Source: Fiscal.ai.